SW, it won't last, russianlinesman and david77 haven't been around for a while (hi rl!)...
If you think about it £3 represents an almost exact doubling of the current NAV. With so many potential winners in the portfolio now (CPS, Sciona, Oxford Immunotec, Polatis, M-Spatial, ZBD etc), if the larger holdings were to succeed and attract exits at 3 or 4 times their current valuations £3 is certainly attainable.
My belief is that in particular Oxford Immunotec, CPS, Sciona and maybe M-Spatial will be doing that in the next year or two.